UY30867A1 - Nuevos analogos de piridina vii 543 - Google Patents

Nuevos analogos de piridina vii 543

Info

Publication number
UY30867A1
UY30867A1 UY30867A UY30867A UY30867A1 UY 30867 A1 UY30867 A1 UY 30867A1 UY 30867 A UY30867 A UY 30867A UY 30867 A UY30867 A UY 30867A UY 30867 A1 UY30867 A1 UY 30867A1
Authority
UY
Uruguay
Prior art keywords
piridina
vii
new analogs
analogs
new
Prior art date
Application number
UY30867A
Other languages
English (en)
Inventor
Johan Johansson
Ruth Bylund
Fredrik Zetterberg
Fabrizio Giordanetto
Peter Bach
Kay Brickmann
Thomas Antonsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39608897&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30867(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY30867A1 publication Critical patent/UY30867A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invencion se refiere a ciertos nuevos análogos de piridina de formula (I) a procesos para preparar dichos compuestos, a su utilidad como inhibidores de P2Y12 y como agentes antitromboticos, etc., su uso como medicamentos en enfermedades cardiovasculares, así como también a composiciones farmacéuticas que los contienen.
UY30867A 2007-01-12 2008-01-11 Nuevos analogos de piridina vii 543 UY30867A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88466007P 2007-01-12 2007-01-12

Publications (1)

Publication Number Publication Date
UY30867A1 true UY30867A1 (es) 2008-09-02

Family

ID=39608897

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30867A UY30867A1 (es) 2007-01-12 2008-01-11 Nuevos analogos de piridina vii 543

Country Status (6)

Country Link
US (1) US20080176827A1 (es)
AR (1) AR064864A1 (es)
CL (1) CL2008000092A1 (es)
TW (1) TW200833333A (es)
UY (1) UY30867A1 (es)
WO (1) WO2008085118A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101506193A (zh) * 2006-07-04 2009-08-12 阿斯利康(瑞典)有限公司 新吡啶类似物
WO2010005385A1 (en) * 2008-07-07 2010-01-14 Astrazeneca Ab 2-amino-6-alkyl substituted pyridine derivatives useful as p2y12 inhibitors 308
WO2010089993A1 (ja) 2009-02-03 2010-08-12 クミアイ化学工業株式会社 縮合環化した２－ピリドン誘導体及び除草剤
WO2013033178A1 (en) 2011-08-30 2013-03-07 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
EP3704127A1 (en) 2017-11-02 2020-09-09 AiCuris GmbH & Co. KG Novel, highly active amino-thiazole substituted indole-2-carboxamides active against the hepatitis b virus (hbv)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156758A (en) * 1999-09-08 2000-12-05 Isis Pharmaceuticals, Inc. Antibacterial quinazoline compounds
DK1257550T3 (da) * 2000-02-04 2006-03-27 Portola Pharm Inc Blodplade-ADP-receptor-inhibitor
US6906063B2 (en) * 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7018985B1 (en) * 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
FR2820057A1 (fr) * 2001-01-30 2002-08-02 Ct De Transfert De Technologie Membrane pour chambre d'encapsulation de cellules produisant au moins une substance biologiquement active et organe bio-artificiel comprenant une telle membrane
US7504497B2 (en) * 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7749981B2 (en) * 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7335648B2 (en) * 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
JP2008500284A (ja) * 2004-05-12 2008-01-10 ブリストル−マイヤーズ　スクイブ　カンパニー 血栓症の治療に有用なｐ２ｙ１レセプターのウレアアンタゴニスト
MXPA06014574A (es) * 2004-06-24 2007-03-12 Incyte Corp Piperidinas n-sustituidas y su uso como farmaceuticos.
BRPI0606437A (pt) * 2005-01-06 2008-03-11 Astrazeneca Ab composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, e, método de tratamento de um distúrbio de agregação de plaqueta
KR20080039405A (ko) * 2005-07-13 2008-05-07 아스트라제네카 아베 신규한 피리딘 유사체
EP2041115A4 (en) * 2006-07-04 2010-07-07 Astrazeneca Ab NEW PYRIDINE ANALOG
CN101506193A (zh) * 2006-07-04 2009-08-12 阿斯利康(瑞典)有限公司 新吡啶类似物
US20090286834A1 (en) * 2006-07-04 2009-11-19 Astrazeneca Ab Pyridine Analogues VI

Also Published As

Publication number Publication date
AR064864A1 (es) 2009-04-29
TW200833333A (en) 2008-08-16
US20080176827A1 (en) 2008-07-24
WO2008085118A1 (en) 2008-07-17
CL2008000092A1 (es) 2008-09-05

Similar Documents

Publication Publication Date Title
ECSP088975A (es) Nuevos análagos de piridina
UY29325A1 (es) Nuevos derivados de 2 - amino-piridina
UY31260A1 (es) Compuestos de pirazol, composiciones conteniendolos y aplicaciones.
UY29667A1 (es) Nuevos compuestos de piridina, composiciones farmaccuticas que los contienen, procedimientos de preparacinn y aplicaciones
UY31524A1 (es) Nuevos compuestos 010
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
CR9463A (es) Pirrolinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion
ECSP099750A (es) Imidazoquinolinas con propiedades inmunomoduladoras
UY30444A1 (es) Derivados de pirimidina, procesos para su preparacinn, composiciones farmaccuticos y usos de los mismos.
UY31546A1 (es) Derivados bis-(sulfonilamino) en terapia 205
CU20110204A7 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
UY31481A1 (es) Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones
UY31468A1 (es) Derivados bis-(sulfonilamino) en terapia 065
UY30976A1 (es) Nuevos derivados de quinolina, composiciones farmaccuticas que los contienen, procesos de preparacion y aplicaciones.
UY30856A1 (es) Nuevos derivados de 2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y principalmente como inhibidores de ikk
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
GT200600144AA (es) 1h-quinazolin-2,4-dionas (solicitud fraccionaria, derivada de la solicitud de patente de invencion pi-2006-00144)
UY29896A1 (es) Nuevos derivados de cromano, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones
ECSP099425A (es) Derivados de amina y su uso en enfermedades mediadas por el adrenorecetor beta 2
HN2008001393A (es) Derivados de 1,2,4,5- tetrahidro -3h- benzazepinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen
UY30865A1 (es) Nuevos analogos de piridina x 161
UY30866A1 (es) Nuevos compuestos de piridina, composiciones farmacéuticas conteniéndolos y aplicaciones (519)
UY31905A (es) Derivados de benzoxazinona, procesos de preparación, composiciones farmacéuticas conteniéndolos y aplicaciones.
UY30868A1 (es) Nuevos compuestos de piridina, composiciones farmacéuticas conteniéndolas y aplicaciones.
UY30933A1 (es) Derivados de pentafluorotiobenzamidoacetonitrilo, composiciones farmacéuticas que contienen tales compuestos y aplicaciones.

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20120611